Intravenous iron in heart failure and chronic kidney disease Patricia Carrilho

Sofosbuvir-based regimens for HCV in stage 4–stage 5 chronic kidney disease. A systematic review with meta-analysis Fabrizio Fabrizi, Roberta Cerutti, Vivek Dixit, Ezequiel Ridruejo

Does uric acid-lowering treatment slow the progression of chronic kidney disease? A meta-analysis of randomized controlled trials Paulo Roberto Bignardi, Danielle Harumi Ido, Felipe Augusto Lopes Garcia, Lucas Mendes Braga, Vinicius Daher Alvares Delfino